- Home
- EWTX vs OPRA Comparison
EWTX vs OPRA Comparison
Compare EWTX & OPRA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EWTX
- OPRA
- Stock Information
- Founded
- EWTX 2017
- OPRA 1996
- Country
- EWTX United States
- OPRA Norway
- Employees
- EWTX N/A
- OPRA N/A
- Industry
- EWTX Biotechnology: Pharmaceutical Preparations
- OPRA Computer Software: Prepackaged Software
- Sector
- EWTX Health Care
- OPRA Technology
- Exchange
- EWTX Nasdaq
- OPRA Nasdaq
- Market Cap
- EWTX 1.6B
- OPRA 1.4B
- IPO Year
- EWTX 2021
- OPRA 2018
- Fundamental
- Price
- EWTX $14.95
- OPRA $17.01
- Analyst Decision
- EWTX Buy
- OPRA Strong Buy
- Analyst Count
- EWTX 10
- OPRA 5
- Target Price
- EWTX $37.90
- OPRA $24.90
- AVG Volume (30 Days)
- EWTX 957.0K
- OPRA 804.0K
- Earning Date
- EWTX 11-06-2025
- OPRA 10-28-2025
- Dividend Yield
- EWTX N/A
- OPRA 4.65%
- EPS Growth
- EWTX N/A
- OPRA N/A
- EPS
- EWTX N/A
- OPRA 0.90
- Revenue
- EWTX N/A
- OPRA $554,721,000.00
- Revenue This Year
- EWTX N/A
- OPRA $26.28
- Revenue Next Year
- EWTX N/A
- OPRA $14.72
- P/E Ratio
- EWTX N/A
- OPRA $19.95
- Revenue Growth
- EWTX N/A
- OPRA 29.84
- 52 Week Low
- EWTX $10.60
- OPRA $12.83
- 52 Week High
- EWTX $38.12
- OPRA $22.50
- Technical
- Relative Strength Index (RSI)
- EWTX 49.70
- OPRA 41.34
- Support Level
- EWTX $14.85
- OPRA $18.39
- Resistance Level
- EWTX $15.84
- OPRA $21.06
- Average True Range (ATR)
- EWTX 1.08
- OPRA 0.98
- MACD
- EWTX -0.06
- OPRA -0.29
- Stochastic Oscillator
- EWTX 31.42
- OPRA 7.02
About EWTX Edgewise Therapeutics Inc.
Edgewise Therapeutics Inc is a clinical-stage biopharmaceutical company. It is focused on the discovery, development, and commercialization of treatments for severe, rare muscle disorders. It is developing orally bioavailable, small molecule therapies for musculoskeletal diseases. The company's product candidates are Sevasemten and EDG-7500. Sevasemten is an orally administered small molecule designed to address the root cause of dystrophinopathies including Duchenne muscular dystrophy (Duchenne) and Becker muscular dystrophy (Becker). The company is currently studying Sevasemten in Phase 2 trials, which are being held in the U.S. and Israel and in certain countries in Europe and Australasia.
About OPRA Opera Limited
Opera Ltd is a world-wide internet brand with a large, engaged, and growing base. It offers users products and services that include a variety of PC and mobile browsers, Opera Gaming portals and development tools, Opera News content recommendation products, and a number of e-commerce products and services. Its browser's features include tabbed browsing, data savings, PC/mobile sync, and numerous features focused on privacy and security, including ad blocking and a built-in VPN. Its browser products include Opera Mini, Opera Browser for Android and iOS, Opera for Computers, Opera GX and Opera GX Mobile, separate browsers tailored for gamers. Geographically, the company generates maximum revenue from the United States, followed by Singapore, Nigeria, Russia, and other locations.